These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37766133)

  • 1. Population-Level Immunity for Transient Suppression of COVID-19 Waves in Japan from April 2021 to September 2022.
    Kodera S; Ueta H; Unemi T; Nakata T; Hirata A
    Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Did the Tokyo Olympic Games enhance the transmission of COVID-19? An interpretation with machine learning.
    Hirata A; Kodera S; Diao Y; Rashed EA
    Comput Biol Med; 2022 Jul; 146():105548. PubMed ID: 35537221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of Real-World Vaccination Effectiveness of mRNA COVID-19 Vaccines against Delta and Omicron Variants in Japan.
    Kodera S; Rashed EA; Hirata A
    Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022.
    Song P; Karako T
    Biosci Trends; 2022 Jan; 15(6):350-352. PubMed ID: 34980786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in-depth appraisal of clinico-biochemical and radiological findings of COVID-19 patients during the COVID-19 pandemic in a dedicated COVID Care Hospital in Eastern India and its outcome in relation to the COVAXIN vaccination status: A 2-year study.
    Rao CM; Mohapatra AK; Patnaik AK; Panda PS; Behera PR
    J Family Med Prim Care; 2023 May; 12(5):971-978. PubMed ID: 37448914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of COVID-19 in Amazonia: A history of government denialism and the risk of a third wave.
    Ferrante L; Duczmal LH; Capanema E; Steinmetz WAC; Almeida ACL; Leão J; Vassão RC; Fearnside PM; Tupinambás U
    Prev Med Rep; 2022 Apr; 26():101752. PubMed ID: 35242505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave - a nationwide study in Japan.
    Tanaka H; Chubachi S; Asakura T; Namkoong H; Azekawa S; Otake S; Nakagawara K; Fukushima T; Lee H; Watase M; Sakurai K; Kusumoto T; Masaki K; Kamata H; Ishii M; Hasegawa N; Okada Y; Koike R; Kitagawa Y; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K
    Int J Infect Dis; 2023 Jul; 132():84-88. PubMed ID: 37086866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 forecasting using new viral variants and vaccination effectiveness models.
    Rashed EA; Kodera S; Hirata A
    Comput Biol Med; 2022 Oct; 149():105986. PubMed ID: 36030722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Vaccination Coverage Disparity and the Dynamics of the COVID-19 Delta and Omicron Waves in the US.
    Cuadros DF; Moreno CM; Musuka G; Miller FD; Coule P; MacKinnon NJ
    Front Med (Lausanne); 2022; 9():898101. PubMed ID: 35775002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
    Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
    JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark.
    Hansen CH; Friis NU; Bager P; Stegger M; Fonager J; Fomsgaard A; Gram MA; Christiansen LE; Ethelberg S; Legarth R; Krause TG; Ullum H; Valentiner-Branth P
    Lancet Infect Dis; 2023 Feb; 23(2):167-176. PubMed ID: 36270311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hybrid immunity, school reopening, and the Omicron variant on the trajectory of the COVID-19 epidemic in India: a modelling study.
    Mozaffer F; Cherian P; Krishna S; Wahl B; Menon GI
    Lancet Reg Health Southeast Asia; 2023 Jan; 8():100095. PubMed ID: 36267800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants.
    Wang J; Chan YC; Niu R; Wong EWM; van Wyk MA
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5.
    Torres C; Nabaes Jodar M; Acuña D; Montaño RMZ; Culasso ACA; Amadio AF; Aulicino P; Ceballos S; Cacciabue M; Debat H; Dus Santos MJ; Eberhardt MF; Espul C; Fay F; Fernández MA; Fernández F; Muñoz JMF; Ferrini F; Gallego F; Giri AA; Cerri A; Bolatti E; Gismondi MI; Goya S; Gramundi I; Irazoqui JM; König GA; Leiva V; Lucero H; Marquez N; Nardi C; Ortiz B; Pianciola L; Pintos CB; Puebla AF; Rastellini CV; Rojas AE; Sfalcin J; Suárez A; Tittarelli E; Toro R; Villanova GV; Ziehm MC; Zimmermann MC; Zunino S; Proyecto Pais Working Group ; Valinotto L; Viegas M
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal Effect of the Tokyo 2020 Olympic and Paralympic Games on the Number of COVID-19 Cases under COVID-19 Pandemic: An Ecological Study Using the Synthetic Control Method.
    Yamamoto N; Mitsuhashi T; Tsuchihashi Y; Yorifuji T
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projection of COVID-19 Positive Cases Considering Hybrid Immunity: Case Study in Tokyo.
    Kodera S; Takada A; Rashed EA; Hirata A
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
    Jung SM; Hayashi K; Kayano T; Nishiura H
    Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the dynamics of the Omicron and Delta variants of the 2019 coronavirus in the presence of vaccination, mask usage, and antiviral treatment.
    Ngonghala CN; Taboe HB; Safdar S; Gumel AB
    Appl Math Model; 2023 Feb; 114():447-465. PubMed ID: 36281307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.